Your browser doesn't support javascript.
loading
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.
Meynard, Guillaume; Mansi, Laura; Lebahar, Pierre; Villanueva, Cristian; Klajer, Elodie; Calcagno, Fabien; Vivalta, Adrian; Chaix, Marie; Collonge-Rame, Marie-Agnès; Populaire, Céline; Algros, Marie-Paule; Colpart, Prudence; Neidich, Julie; Pivot, Xavier; Curtit, Elsa.
  • Meynard G; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Mansi L; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Lebahar P; Pathway Genomics Corporation, San Diego, CA 92121, USA.
  • Villanueva C; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Klajer E; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Calcagno F; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Vivalta A; Pathway Genomics Corporation, San Diego, CA 92121, USA.
  • Chaix M; Department of Medical Oncology, University Hospital, 21079 Dijon, France.
  • Collonge-Rame MA; University of Franche-Comté, 25000 Besançon, France.
  • Populaire C; University of Franche-Comté, 25000 Besançon, France.
  • Algros MP; University of Franche-Comté, 25000 Besançon, France.
  • Colpart P; University of Franche-Comté, 25000 Besançon, France.
  • Neidich J; Pathway Genomics Corporation, San Diego, CA 92121, USA.
  • Pivot X; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
  • Curtit E; Department of Medical Oncology, University Hospital, 25000 Besançon, France.
Oncol Rep ; 37(3): 1573-1578, 2017 Mar.
Article en En | MEDLINE | ID: mdl-28184945
ABSTRACT
Hereditary breast and ovarian cancer syndrome is an autosomal dominant disease caused primarily by germline mutations in the BRCA1 or BRCA2 gene. Rare cases of double heterozygosity for BRCA1 and BRCA2 mutations have been reported quite exceptionally in non-Ashkenazi individuals. We describe the case of a woman who developed a bilateral breast cancer, discovered concomitantly, at 46 years old. Biopsies confirmed the presence of two breast cancers with distinct histology. BRCA analysis was tested due to a positive family history of breast cancer, and two pathogenic monoallelic mutations were detected, one in the BRCA1 gene and one in the BRCA2 gene. There is no known Ashkenazi Jewish ancestry. We report the first description of a never described double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient, with two distinct histology, and two distinct mutations.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Mutación Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Mutación Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article